GGrantIndex
← Leaderboards

Pamala A Jacobson

Hennepin Healthcare Research Institute

$6,770,762
Attributed
$8,671,218
Total exposure
12
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200524
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$8,671,218 · 12

By mechanism

U19$4,089,091 · 2
R01$3,600,454 · 1
K23$609,735 · 1
M01$371,938 · 8

Top collaborators

Most similar at Hennepin Healthcare Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Drug Kinetics

Research focus

Drug KineticsDoseTransplant RecipientsKidney TransplantationImmunosuppressive AgentsPharmaceutical PreparationsImmuneAcuteLeadToxic EffectTacrolimusGenetic VariantEnrollmentCohortProspectiveMycophenolic AcidLeukopeniaGenesAnemiaMycophenolate MofetilBloodTransplantationVariantAdverse Effects

Grant awards (29)

Gut Microbiota and Effect on Immune Suppressants in Transplantation$400,917
R01 · FY2024 · AI
Gut Microbiota and Effect on Immune Suppressants in Transplantation$349,797
R01 · FY2024 · AI
Gut Microbiota and Effect on Immune Suppressants in Transplantation$666,666
R01 · FY2023 · AI
Gut Microbiota and Effect on Immune Suppressants in Transplantation$727,720
R01 · FY2021 · AI
Gut Microbiota and Effect on Immune Suppressants in Transplantation$716,882
R01 · FY2020 · AI
Gut Microbiota and Effect on Immune Suppressants in Transplantation$738,472
R01 · FY2019 · AI
Pharmacogenomics of Immune Suppressants in Kidney Transplantation$371,408
U19 · FY2015 · AI · contact PI
Pharmacogenomics of Immune Suppressants in Kidney Transplantation$1,239,887
U19 · FY2014 · AI · contact PI
Pharmacogenomics of Immune Suppressants in Kidney Transplantation$231,034
U19 · FY2013 · AI · contact PI
Pharmacogenomics of Immune Suppressants in Kidney Transplantation$404,689
U19 · FY2012 · AI · contact PI
Pharmacogenomics of Immune Suppressants in Kidney Transplantation$144,604
U19 · FY2011 · AI · contact PI
Pharmacogenetics of Immune Suppressants in Kidney Transplantation$351,690
U19 · FY2010 · AI · contact PI
Pharmacogenetics of Immune Suppressants in Kidney Transplantation$381,554
U19 · FY2009 · AI · contact PI
GENOMICS OF KIDNEY TRANSPLANTATION$3,659
M01 · FY2009 · RR · contact PI
Pharmacogenetics of Immune Suppressants in Kidney Transplantation$360,472
U19 · FY2008 · AI · contact PI
MT2003-24-FLUDARABINE PHARMACOKINETICS IN NONMYELOABLATIVE HEMATOPOIETIC CELL TR$43,553
M01 · FY2008 · RR · contact PI
Pharmacogenetics of Immune Suppressants in Kidney Transplantation$370,268
U19 · FY2007 · AI · contact PI
MT2003-24-FLUDARABINE PHARMACOKINETICS IN NONMYELOABLATIVE HEMATOPOIETIC CELL TR$98,416
M01 · FY2007 · RR · contact PI
Pharmacogenetics of Immune Suppressants in Kidney Transplantation$233,485
U19 · FY2006 · AI · contact PI
Optimizing Stem Cell Transplant for Cancer$127,318
K23 · FY2006 · CA · contact PI
FLUDARABINE PHARMACOKINETICS IN NONMYELOABLATIVE HEMATOPOIETIC CELL TRANSPLANTAT$88,754
M01 · FY2006 · RR · contact PI
Optimizing Stem Cell Transplant for Cancer$124,553
K23 · FY2005 · CA
FLUDARABINE PHARMACOKINETICS IN NONMYELOABLATIVE HEMATOPOIETIC CELL TRANSPLANTAT$45,939
M01 · FY2005 · RR
MYCHOPHENOLATE IN NONMYELOABLATIVE STEM CELL TRANSPLANT$43,155
M01 · FY2005 · RR
Optimizing Stem Cell Transplant for Cancer$121,868
K23 · FY2004 · CA
Mychophenolate in Nonmyeloablative Stem Cell Transplant$47,353
M01 · FY2004 · RR
Cyclophosphamide Pharmacogenetics$1,109
M01 · FY2004 · RR
Optimizing Stem Cell Transplant for Cancer$119,263
K23 · FY2003 · CA
Optimizing Stem Cell Transplant for Cancer$116,733
K23 · FY2002 · CA